With 26% Growth in H1, Neimeth Outshines Peers in Revenue Generation
Neimeth International Pharmaceuticals Plc emerged as the fastest-growing listed pharmaceutical company by revenue in the first half of 2026, recording a 26 per cent year-on-year increase in sales despite a
We haven't written up this one. This Day has the full story — the link below goes straight to it.